Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Roberto Romoli"'
Autor:
Giuseppe Chiumello, Sabine Costagliola, Maria Carla Proverbio, Paolo Beck-Peccoz, Roberto Romoli, Maria Cristina Vigone, Luisella Alberti, Giovanna Weber, Luca Persani, Benedetta Boldrighini
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 87:2549-2555
Germline loss-of-function mutations of TSH receptor (TSHR) gene have been described in families with partial or complete TSH resistance. Large TSH elevations were generally found in the patients with homozygous or compound heterozygous mutations. In
Autor:
Marco Losa, Andrea Lania, Roberto Romoli, Bruno Ambrosi, Anna Spada, Paolo Beck-Peccoz, E. Gangi, D. Meringolo, Giovanni Faglia, P. Travaglini
Publikováno v:
European Journal of Clinical Investigation. 32:335-340
Background Several in vitro studies suggest that gonadotropin-secreting pituitary adenomas (Gn-omas) and non functioning pituitary adenomas (NFPA) originate from gonadotroph cells. Patients with Gn-oma and NFPA frequently show abnormal gonadotropin r
Autor:
Roberto Romoli, Luca Persani, John C. Achermann, Giorgio Borretta, Anna Spada, Paolo Beck-Peccoz, J. Larry Jameson, Giovanna Mantovani, Gokhan Ozisik
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 87:44-48
Mutations in the orphan nuclear receptor DAX-1 cause X-linked adrenal hypoplasia congenita. Affected boys usually present with primary adrenal failure in early infancy or childhood. Impaired sexual development because of hypogonadotropic hypogonadism
Autor:
G. Ghilardi, Paolo Beck-Peccoz, Roberto Romoli, Luisella Alberti, N. Cerutti, Deborah Mannavola, Laura Fugazzola
Publikováno v:
Clinical Endocrinology. 56:53-63
Summary background Occurrence in a familial setting is well established for medullary thyroid carcinoma (MTC) and has been more recently reported for papillary thyroid cancer (PTC). Germline mutations or rearrangements of the RET proto-oncogene are t
Autor:
Anna Spada, Giovanna Mantovani, Giovanna Weber, Roberto Romoli, E. De Menis, V. Brunelli, S. Beccio, Paolo Beck-Peccoz
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 85:4243-4248
Pseudohypoparathyroidism (PHP) refers to two major variants that generally coexist in the same family, PHP type Ia (PHP Ia), in which both PTH resistance and a constellation of physical features, termed Albright's hereditary osteodystrophy (AHO), are
Autor:
Sebastiano Filetti, Giovanna Mantovani, Anna Spada, Marco Conti, Luca Persani, Luisella Alberti, Roberto Romoli, Andrea Lania
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 85:2872-2878
Thyrocytes largely depend on cAMP signaling for replication and differentiation. This pathway may be constitutively activated by mutations of the TSH receptor (TSHR) and Gsalpha in autonomous thyroid adenomas (ATAs). Because steady state cAMP results
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:2848-2853
Extracellular Ca2+-sensing receptor (CaSR) has been recently identified in rat and mouse pituitary and in AtT-20 cells. The aim of the study was to investigate the presence of CaSR in the human pituitary and its signaling pathway. Normal parathyroid
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:2486-2492
Variation in asparagine-linked carbohydrate chains have a major impact on TSH biological properties. In particular, highly sialylated TSH is characterized by impaired intrinsic bioactivity and prolonged half-life. The aim of the present study was to
Autor:
Anna Spada, Donatella Cortelazzi, Roberto Romoli, Luca Persani, Paolo Beck-Peccoz, S. Borgato
Publikováno v:
Scopus-Elsevier
It has been reported that serum FSH bioactivity and inhibin levels can be used as markers of the presence of true gonadotropin-secreting pituitary adenoma (Gn-oma). To verify this hypothesis, we have investigated the bioactivity of FSH and serum inhi
Publikováno v:
Archives de Pédiatrie. 5:S380-S384
The different types of activating mutations of LH and FSH receptors genes are described. They result in a constitutive permanent activation of the LH or FSH function responsible for functional disorders which is also observed in some ovarian tumours.